What is the typical dose of Pepcid (famotidine) for itching?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 1, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pepcid (Famotidine) Dosing for Itching

For pruritus management, famotidine 20 mg intramuscularly or orally is effective, though hydroxyzine 25-50 mg at bedtime is the preferred first-generation antihistamine for nighttime itching based on current dermatology guidelines. 1, 2

Evidence for Famotidine in Pruritus

Famotidine, an H2-receptor antagonist, has demonstrated efficacy in treating itching associated with acute urticaria. A controlled trial showed that famotidine 20 mg intramuscularly significantly reduced pruritus intensity, urticaria severity, and body surface area involvement without causing sedation, with comparable efficacy to diphenhydramine 50 mg. 3 This non-sedating profile makes it particularly advantageous for daytime use.

Clinical Context and Positioning

While famotidine shows promise for pruritus, current guidelines prioritize H1-antihistamines as the primary treatment for itching. 1 The American Academy of Dermatology recommends:

  • Non-sedating second-generation H1-antihistamines (loratadine, fexofenadine) for daytime pruritus management 1, 4
  • First-generation H1-antihistamines like hydroxyzine 25-50 mg at bedtime for nighttime itching 1, 2

When to Consider H2-Antagonists

H2-antihistamines like famotidine should be considered as adjunctive therapy when H1-antihistamines provide inadequate response. 1 The British Association of Dermatologists suggests adding H2-antihistamines when increasing H1-antihistamine doses or switching agents fails to control symptoms. 1

For combination therapy in moderate to severe pruritus, famotidine 20 mg twice daily can be added to daytime non-sedating H1-antihistamines and nighttime hydroxyzine. 2, 4

Specific Dosing Recommendations

Based on available evidence:

  • Acute urticaria with pruritus: Famotidine 20 mg intramuscularly or orally as a single dose 3
  • Chronic pruritus requiring H2-blockade: Famotidine 20 mg orally twice daily (extrapolated from standard H2-antagonist dosing for gastric acid suppression) 5, 6

Important Caveats

Famotidine's primary FDA-approved indication is gastric acid suppression, not pruritus. 5, 6 Its use for itching represents off-label prescribing based on limited evidence. The single published trial for urticaria-associated pruritus involved only 25 patients. 3

In cardiovascular patients on dual antiplatelet therapy (aspirin plus clopidogrel), famotidine 20 mg twice daily is specifically recommended over proton pump inhibitors because H2-blockers do not interfere with clopidogrel's antiplatelet activity. 7 This makes famotidine particularly suitable for pruritus management in this population.

Practical Algorithm

  1. First-line daytime: Non-sedating H1-antihistamine (loratadine 10 mg daily or fexofenadine 180 mg daily) 4
  2. First-line nighttime: Hydroxyzine 25-50 mg at bedtime 1, 2
  3. Inadequate response: Increase H1-antihistamine dose or add famotidine 20 mg twice daily 1, 2
  4. Acute urticaria with severe pruritus: Consider famotidine 20 mg IM for rapid, non-sedating relief 3

Dose adjustments are necessary in renal impairment, as famotidine is 70% renally eliminated with a half-life of 2.8 hours that prolongs nonlinearly with decreased kidney function. 5

References

Guideline

Hydroxyzine for Pruritus Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Hydroxyzine Pamoate Dosing for Pruritus

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Famotidine in the treatment of acute urticaria.

Clinical and experimental dermatology, 2000

Guideline

Severe Pruritus Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Clinical pharmacology of famotidine: a summary.

Journal of clinical gastroenterology, 1987

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.